Angiography-based physiology to guide coronary revascularization (Registro nro. 22722)

000 -Cabecera
Campo de control interno 02799nam a2200289 4500
001 - Número de control
control field ESSALUD
005 - Fecha y hora de la última transacción
Campo de control 20260804122304.0
007 - Tipo material - Descripcion fisica - info general
Tipo material - Descripcion fisica - info general ta
008 - Elementos de Longitud Fija - Información General
Elementos de Longitud Fija - Información t pe ||||| |||| 00| 0 spa d
040 ## - Origen de la Catalogación
Origen de la Catalogación BMG
041 ## - Idioma
Idioma eng
100 ## - Autor
Autor Daemen, Joost
Rol del Autor Autor
9 (RLIN) 53647
245 ## - Titulo
Titulo Angiography-based physiology to guide coronary revascularization
300 ## - Páginas
Paginación páginas: 20-31
520 ## - Resumen
Resumen Background: Current society guidelines recommend physiological assessment of intermediate coronary lesions to guide revascularization. Data regarding revascularization guided by vessel fractional flow reserve (vFFR), derived from three-dimensional quantitative coronary angiography without the need for a pressure wire or hyperemic agent, as compared with pressure-wire–based fractional flow reserve (FFR), are lacking.<br/>Methods: We conducted an international, open-label, randomized, noninferiority trial at 37 sites in Europe. Patients with intermediate coronary-artery lesions (diameter stenosis of 30 to 80%) who presented with chronic or acute coronary syndromes were randomly assigned in a 1:1 ratio to undergo either vFFR-guided or FFR-guided revascularization of the intermediate coronary-artery lesions. The primary end point was a composite of death from any cause, any myocardial infarction, or any revascularization at 1 year. The noninferiority margin was 3.0 percentage points.<br/>Results: The primary end point was assessed in 1116 patients in the vFFR group and 1095 in the FFR group. The mean age of the patients was 67 years, 24.3% were women, 18.7% presented with an acute coronary syndrome, and 26.6% had diabetes mellitus. At 1 year, a primary end-point event had occurred in 80 patients (Kaplan–Meier estimate, 7.5%) in the vFFR group and in 79 patients (Kaplan–Meier estimate, 7.5%) in the FFR group (risk difference, −0.02 percentage points; 95% confidence interval, −2.25 to 2.21; P=0.004 for noninferiority). The incidence of serious adverse events appeared to be similar in the two groups.<br/>Conclusions: Among patients with intermediate coronary lesions, vFFR-guided revascularization was noninferior to FFR-guided revascularization with respect to a composite of death, myocardial infarction, or revascularization at 1 year. <br/>
650 ## - Temas - Descriptores
Temas - Descriptores CARDIOLOGÍA GENERAL
9 (RLIN) 53638
650 ## - Temas - Descriptores
Temas - Descriptores ENFERMEDAD CORONARIA
9 (RLIN) 14895
650 ## - Temas - Descriptores
Temas - Descriptores INFARTO DE MIOCARDIO
9 (RLIN) 13202
700 ## - Autor Personal
Autor Personal Van der Eijk, Jari A.
9 (RLIN) 53648
700 ## - Autor Personal
Autor Personal Barbierato, Marco
9 (RLIN) 53649
700 ## - Autor Personal
Autor Personal Byrne, Robert A.
9 (RLIN) 38050
700 ## - Autor Personal
Autor Personal Canova, Paolo
9 (RLIN) 53650
700 ## - Autor Personal
Autor Personal De Maria, Giovanni L.
9 (RLIN) 53651
700 ## - Autor Personal
Autor Personal Van Belle, Eric
9 (RLIN) 53652
773 0# - Revista (Relacion con el numero)
Host Biblionumber 22717
Host Itemnumber 22634
Ciudad, Editorial Massachusetts NEJM Group
Codigo barras item/ejemplar NEJM001
Titulo de la Revista The New England Journal of Medicine
Número de control de registro ESSALUD
ISSN 0028-4793
942 ## - Elementos de Koha
Tipo de Documento Artículos
Fecha procesamiento 2026-07-31
Catalogador sqb

No hay ítems disponibles.